Skip to main content
Top
Published in: Journal of General Internal Medicine 6/2020

01-06-2020 | Diabetes Prevention | Original Research: Qualitative Research

Barriers and Facilitators to Real-world Implementation of the Diabetes Prevention Program in Large Healthcare Systems: Lifestyle Coach Perspectives

Authors: Meghan C. Halley, PhD, MPH, John Petersen, BS, Catherine Nasrallah, MPH, CHES, Nina Szwerinski, MS, Robert Romanelli, PhD, MPH, Kristen M. J. Azar, RN, BSN, MSN/MPH

Published in: Journal of General Internal Medicine | Issue 6/2020

Login to get access

Abstract

Background

Group-based lifestyle change programs based on the Diabetes Prevention Program (DPP) are associated with clinically significant weight loss and decreases in cardiometabolic risk factors. However, these benefits depend on successful real-world implementation. Studies have examined implementation in community settings, but less is known about integration in healthcare systems, and particularly in large, multi-site systems with the potential for extended reach.

Objective

To examine the barriers and facilitators to successful DPP implementation in a large multi-site healthcare system.

Design

Semi-structured interviews, based on the RE-AIM framework, were conducted in person for 30–90 min each.

Participants

Past and present DPP lifestyle coaches in the healthcare system identified using purposive sampling.

Approach

Thematic analysis of qualitative data to identify key factors influencing the success of DPP implementation. An iterative consensus process was used to model the relationships among factors.

Key Results

We conducted 33 interviews across 20 clinic sites serving 12 counties. Participants described six key factors as potential barriers or facilitators to implementation, including (1) Broader Context, including the surrounding physical and sociodemographic context; (2) Institutional Context, including finances, infrastructure, and personnel; (3) Program Provision, including curriculum, administration, cost, goals, and visibility; (4) Recruitment Process, including screening and referrals; (5) Lifestyle Coaches, including their characteristics, behaviors, and morale; and (6) Cohort, including group attrition/retention and interpersonal dynamics. These factors were both highly interconnected in their impact on implementation and widely variable across sites within the healthcare system, as illustrated in our multi-level conceptual framework.

Conclusions

This study identified key factors that could serve as barriers or facilitators in the implementation of DPP in large healthcare systems, from the perspective of lifestyle coaches. With further examination, the conceptual model presented here may be used for planning and managing the implementation of group-based behavioral interventions in these settings.
Appendix
Available only for authorised users
Literature
1.
go back to reference Diabetes Prevention Program Research Group. The diabetes prevention program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25:2165–2171. Diabetes Prevention Program Research Group. The diabetes prevention program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25:2165–2171.
2.
go back to reference Brink S. The Diabetes Prevention Program: how the participants did it. Health Aff (Millwood). 2009;28(1):57–62.PubMed Brink S. The Diabetes Prevention Program: how the participants did it. Health Aff (Millwood). 2009;28(1):57–62.PubMed
3.
go back to reference The Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care. 2005;28(4):888–94.PubMedCentral The Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care. 2005;28(4):888–94.PubMedCentral
4.
go back to reference Orchard TJ, Temprosa M, Goldberg R, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142(8):611–619.PubMedPubMedCentral Orchard TJ, Temprosa M, Goldberg R, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142(8):611–619.PubMedPubMedCentral
5.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med. 2002; 346(6):393–403.PubMed Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med. 2002; 346(6):393–403.PubMed
6.
go back to reference Knowler WC, Fowler SE, Diabetes Prevention Program Group, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (London, England). 2009;374(9702):1677–1686. Knowler WC, Fowler SE, Diabetes Prevention Program Group, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (London, England). 2009;374(9702):1677–1686.
8.
go back to reference Parikh P, Simon EP, Fei K, Looker H, Goytia C, Horowitz CR. Results of a pilot diabetes prevention intervention in East Harlem, New York City: Project HEED. Am J Public Health. 2010; 100(suppl 1):S232–S239.PubMedPubMedCentral Parikh P, Simon EP, Fei K, Looker H, Goytia C, Horowitz CR. Results of a pilot diabetes prevention intervention in East Harlem, New York City: Project HEED. Am J Public Health. 2010; 100(suppl 1):S232–S239.PubMedPubMedCentral
9.
go back to reference Katula JA, Vitolins MZ, Rosenberger EL, et al. One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project [published correction appears in Diabetes Care. 2012 Feb;35(2):455]. Diabetes Care. 2011;34(7):1451–1457. doi:https://doi.org/10.2337/dc10-2115 PubMedPubMedCentral Katula JA, Vitolins MZ, Rosenberger EL, et al. One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project [published correction appears in Diabetes Care. 2012 Feb;35(2):455]. Diabetes Care. 2011;34(7):1451–1457. doi:https://​doi.​org/​10.​2337/​dc10-2115 PubMedPubMedCentral
12.
go back to reference Ma J, Yank V, Xiao L, et al. Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern Med. 2013;173(2):113–121.PubMed Ma J, Yank V, Xiao L, et al. Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern Med. 2013;173(2):113–121.PubMed
13.
go back to reference Aziz Z, Absetz P, Oldroyd J, Pronk NP, Oldenburg B. A systematic review of real-world diabetes prevention programs: learnings from the last 15 years. Implement Sci. 2015;10:172.PubMedPubMedCentral Aziz Z, Absetz P, Oldroyd J, Pronk NP, Oldenburg B. A systematic review of real-world diabetes prevention programs: learnings from the last 15 years. Implement Sci. 2015;10:172.PubMedPubMedCentral
15.
go back to reference Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322–1327.PubMedPubMedCentral Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322–1327.PubMedPubMedCentral
16.
go back to reference Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012;31(1):67–75.PubMed Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012;31(1):67–75.PubMed
17.
go back to reference Eaglehouse YL, Rockette-Wagner B, Kramer MK, et al. Physical Activity Levels in a Community Lifestyle Intervention: A Randomized Trial. Transl J Am Coll Sports Med. 2016;1(5):45–51.PubMedPubMedCentral Eaglehouse YL, Rockette-Wagner B, Kramer MK, et al. Physical Activity Levels in a Community Lifestyle Intervention: A Randomized Trial. Transl J Am Coll Sports Med. 2016;1(5):45–51.PubMedPubMedCentral
18.
go back to reference Whittemore R. A systematic review of the translational research on the Diabetes Prevention Program. Transl Behav Med. 2011;1(3):480–491.PubMedPubMedCentral Whittemore R. A systematic review of the translational research on the Diabetes Prevention Program. Transl Behav Med. 2011;1(3):480–491.PubMedPubMedCentral
19.
go back to reference Wardian JL, True MW, Sauerwein TJ, Watson NA, Hoover AM. Evaluation of the Group Lifestyle Balance Program in a Military Setting: An Investment Worth Expanding. Mil Med. 2018;183(1–2):e138-e143.PubMed Wardian JL, True MW, Sauerwein TJ, Watson NA, Hoover AM. Evaluation of the Group Lifestyle Balance Program in a Military Setting: An Investment Worth Expanding. Mil Med. 2018;183(1–2):e138-e143.PubMed
20.
go back to reference Almeida FA, Shetterly S, Smith-Ray RL, Estabrooks PA. Reach and effectiveness of a weight loss intervention in patients with prediabetes in Colorado. Preventing chronic disease. 2010;7(5):A103.PubMedPubMedCentral Almeida FA, Shetterly S, Smith-Ray RL, Estabrooks PA. Reach and effectiveness of a weight loss intervention in patients with prediabetes in Colorado. Preventing chronic disease. 2010;7(5):A103.PubMedPubMedCentral
21.
go back to reference Amundson HA, Butcher MK, Gohdes D, et al. Translating the diabetes prevention program into practice in the general community: findings from the Montana Cardiovascular Disease and Diabetes Prevention Program. Diabetes Educ. 2009;35(2):209–210, 213–204, 216–220 passim.PubMed Amundson HA, Butcher MK, Gohdes D, et al. Translating the diabetes prevention program into practice in the general community: findings from the Montana Cardiovascular Disease and Diabetes Prevention Program. Diabetes Educ. 2009;35(2):209–210, 213–204, 216–220 passim.PubMed
22.
go back to reference Jiang L, Manson SM, Beals J, et al. Translating the Diabetes Prevention Program into American Indian and Alaska Native communities: results from the Special Diabetes Program for Indians Diabetes Prevention demonstration project. Diabetes Care. 2013;36(7):2027–2034.PubMedPubMedCentral Jiang L, Manson SM, Beals J, et al. Translating the Diabetes Prevention Program into American Indian and Alaska Native communities: results from the Special Diabetes Program for Indians Diabetes Prevention demonstration project. Diabetes Care. 2013;36(7):2027–2034.PubMedPubMedCentral
25.
go back to reference Race/Ethnicity of Individual, 2016 American Community Survey 1-year estimates. 2016, US Census Bureau. Race/Ethnicity of Individual, 2016 American Community Survey 1-year estimates. 2016, US Census Bureau.
26.
go back to reference Income/Earnings (Households), 2016 American Community Survey 1-year estimates. 2016, US Census Bureau. Income/Earnings (Households), 2016 American Community Survey 1-year estimates. 2016, US Census Bureau.
27.
go back to reference Kramer MK, McWilliams JR, Chen HY, Siminerio LM. A community-based diabetes prevention program: evaluation of the group lifestyle balance program delivered by diabetes educators. Diabetes Educ. 2011;37(5):659–68.PubMed Kramer MK, McWilliams JR, Chen HY, Siminerio LM. A community-based diabetes prevention program: evaluation of the group lifestyle balance program delivered by diabetes educators. Diabetes Educ. 2011;37(5):659–68.PubMed
28.
go back to reference Kramer MK, Kriska AM, Venditti EM, et al. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery. Am J Prev Med. 2009;37(6). Kramer MK, Kriska AM, Venditti EM, et al. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery. Am J Prev Med. 2009;37(6).
29.
go back to reference Betts AC, Froehlich-Grobe K. Accessible weight loss: Adapting a lifestyle intervention for adults with impaired mobility. Disabil Health J. 2017;10(1):139–44.PubMed Betts AC, Froehlich-Grobe K. Accessible weight loss: Adapting a lifestyle intervention for adults with impaired mobility. Disabil Health J. 2017;10(1):139–44.PubMed
31.
go back to reference Romanelli RJ, Sudat S, Huang Q, Pressman AR, Azar KMJ. Early weight loss and treatment response: Data from a lifestyle change program in clinical practice. Am J Prev Med 2019, In Press Romanelli RJ, Sudat S, Huang Q, Pressman AR, Azar KMJ. Early weight loss and treatment response: Data from a lifestyle change program in clinical practice. Am J Prev Med 2019, In Press
32.
go back to reference Chaudoir SR, Dugan AG, Barr CH. Measuring factors affecting implementation of health innovations: a systematic review of structural, organizational, provider, patient, and innovation level measures. Implement Sci. 2013;8:22.PubMedPubMedCentral Chaudoir SR, Dugan AG, Barr CH. Measuring factors affecting implementation of health innovations: a systematic review of structural, organizational, provider, patient, and innovation level measures. Implement Sci. 2013;8:22.PubMedPubMedCentral
33.
go back to reference Miles M, Huberman A, Saldana J. Qualitative Data Analysis: A Methods Sourcebook. 3rd ed. Thousand Oaks, CA: SAGE Publications, Inc; 2014. Miles M, Huberman A, Saldana J. Qualitative Data Analysis: A Methods Sourcebook. 3rd ed. Thousand Oaks, CA: SAGE Publications, Inc; 2014.
34.
go back to reference Dedoose Version 8.0.35, web application for managing, analyzing, and presenting qualitative and mixed method research data [Internet]. Los Angeles (CA): SocioCultural Research Consultants, LLC; c2018 [cited 2019 Jun 6]. Available from: www.dedoose.com. Dedoose Version 8.0.35, web application for managing, analyzing, and presenting qualitative and mixed method research data [Internet]. Los Angeles (CA): SocioCultural Research Consultants, LLC; c2018 [cited 2019 Jun 6]. Available from: www.​dedoose.​com.
35.
go back to reference Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.PubMedPubMedCentral Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.PubMedPubMedCentral
36.
go back to reference Proctor EK, Landsverk J, Aarons G, Chambers D, Glisson C, Mittman B. Implementation Research in Mental Health Services: an Emerging Science with Conceptual, Methodological, and Training challenges. Adm Policy Ment Health. 2009;36(1):24–34.PubMed Proctor EK, Landsverk J, Aarons G, Chambers D, Glisson C, Mittman B. Implementation Research in Mental Health Services: an Emerging Science with Conceptual, Methodological, and Training challenges. Adm Policy Ment Health. 2009;36(1):24–34.PubMed
37.
go back to reference Shortell SM. Increasing value: a research agenda for addressing the managerial and organizational challenges facing health care delivery in the United States. Med Care Res Rev. 2004;61(3 Suppl):12s–30s.PubMed Shortell SM. Increasing value: a research agenda for addressing the managerial and organizational challenges facing health care delivery in the United States. Med Care Res Rev. 2004;61(3 Suppl):12s–30s.PubMed
38.
go back to reference Rogers EM. Diffusion of innovations 5th ed. New York: Free Press; 2003. Rogers EM. Diffusion of innovations 5th ed. New York: Free Press; 2003.
39.
go back to reference Durlak JA, DuPre EP. Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation. Am J Commun Psychol. 2008;41(3–4):327–350. Durlak JA, DuPre EP. Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation. Am J Commun Psychol. 2008;41(3–4):327–350.
Metadata
Title
Barriers and Facilitators to Real-world Implementation of the Diabetes Prevention Program in Large Healthcare Systems: Lifestyle Coach Perspectives
Authors
Meghan C. Halley, PhD, MPH
John Petersen, BS
Catherine Nasrallah, MPH, CHES
Nina Szwerinski, MS
Robert Romanelli, PhD, MPH
Kristen M. J. Azar, RN, BSN, MSN/MPH
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 6/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05744-y

Other articles of this Issue 6/2020

Journal of General Internal Medicine 6/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.